Teleflex, Inc. (TFX)
142.52
+2.04
(+1.45%)
USD |
NYSE |
Sep 02, 13:15
Teleflex Research and Development Expense (Annual) : 144.78M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 144.78M |
| December 31, 2024 | 109.02M |
| December 31, 2023 | 154.35M |
| December 31, 2022 | 153.82M |
| December 31, 2021 | 130.84M |
| December 31, 2020 | 119.75M |
| December 31, 2019 | 113.86M |
| December 31, 2018 | 106.21M |
| Date | Value |
|---|---|
| December 31, 2017 | 84.77M |
| December 31, 2016 | 58.58M |
| December 31, 2015 | 52.12M |
| December 31, 2014 | 61.04M |
| December 31, 2013 | 65.04M |
| December 31, 2012 | 56.28M |
| December 31, 2011 | 48.73M |
| December 31, 2010 | 42.62M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Globus Medical, Inc. | 146.94M |
| Boston Scientific Corp. | 2.052B |
| Penumbra, Inc. | 69.43M |
| Alphatec Holdings, Inc. | 76.27M |
| Becton, Dickinson & Co. | 1.265B |